Report Description Table of Contents Introduction: - In 2020, the valuation of the Coronary Stents Market was USD 8.171 Billion. It is predicted to reach $11.237 billion by 2028, representing a CAGR of 4.78 percent throughout the forecasted period of 2020-2028. Coronary stents are the flexible mesh tubes inserted into the arteries to substantially improve the overall blood flow process and prevent the heart muscles from further damage. It is widely implemented during a surgical procedure to keep the arteries open and effectively prevent them from getting blood clogged. According to World Health Organisation, cardiovascular diseases are one of the leading causes of mortality, resulting in up to 18 million deaths each year, thus resulting in approximately 32.43% of the total number of deaths worldwide. Furthermore, one-third of these deaths occur among people under 70 years of age. Therefore, the continuous rising prevalence of cardiovascular diseases (CVDs), such as heart attack and stroke, together with the growing geriatric population, is guaranteed to propel the growth of the Coronary Stent Market during the forecasted period. COVID-19 Impact on Coronary Stents Market: - The COVID-19 outbreak had a considerable impact on the overall market growth rate. This deadly pandemic has led to a substantial rise in myocardial infarction affecting the overall cardiovascular system, especially of the elderly population who were victims of the Covid-19 outbreak. During this period, there is an utmost need for a conservative approach for patients with acute cardiovascular diseases. The invention of some efficient antiproliferative drugs and polymers for controlling, releasing, and allowing adequate endothelialization along with the optimal duration of the antiplatelet regimen will drastically boost the entire market growth amidst the pandemic. Market Dynamics: - Market Drivers: - The high increase in the rate of cardiovascular diseases such as stroke and heart attacks, and the continuous rising of the senior population worldwide, are the two main reasons that are widely simulating the growth of this market. The widespread use of Alcohol, Tobacco, and Stress is also considered a pivotal contributor to heart ailments, thereby driving the market growth. The Spike in the number of percutaneous coronary intervention (PCI) methods over the last few years has also contributed immensely to the acceleration process of the overall market growth rate. Restraints: - In-stent restenosis (ISR) is the main reason that obstructs this market's growth as it results in gradual re-narrowing of the stented coronary artery lesion because of arterial damage with subsequent neointimal tissue proliferation. The occurrence of in-stent restenosis (ISR) remains an intimidating challenge despite several advancements in coronary intervention technology.Moreover, Angiographic Restonisis is also one of the major problems that have been reported in as many as 50% of the patients within six months of balloon angioplasty surgery. In addition, it has led to repeated target-vessel revascularization in (20-30)% of the cardiac patients. Opportunities: - Coronary angioplasty with stenting is estimated to revolutionize the treatment of arterial diseases. Approximately 30 % of patients across the globe will experience restenosis in the future, which can be successfully treated by implementing this highly upgraded and modernized technique. The new Bioresorbable Vascular Scaffold (BVS) is another widely adopted cardiac surgery method that is expected to witness massive growth in the future. The overall BVS market is growing rapidly at a CAGR of 12.47%, with overall revenue of USD 210.78 Million in 2020. It is expected to gain a significant landmark of USD 539.7 Million in 2028. BVS provides adequate radial support for a long period to avoid early recoil and releases antiproliferative drugs to prevent restenosis. There has been a rising preference for minimally invasive surgeries (MIS), as it provides shorter hospital stays and facilitates a quick recovery, and this approach will gain substantial market growth in the future. MIS market is expanding steadily with an overall growth rate of 7.51% and is estimated to reach a value of USD 33.667 Billion in 2028. Global Coronary Stents Market: - Segmentation Analysis: The Coronary Stents market is broadly segmented based on Type, Mode of Delivery, End User, and Regions. Based on Type: Bare-Metal Stents Drug-Eluting Stents Bioabsorbable Stents Based on Mode of Delivery: Balloon-Expandable Stents Self-Expanding Stents Based on End-User: Hospitals Cardiac Centers Ambulatory Surgical Centers (ASCs) Based on Region: North America US Canada Mexico Rest of North America Europe Germany France U.K Netherlands Switzerland Finland Belgium Russia Italy Spain Turkey Rest of Europe Asia Pacific China Japan India South Korea Singapore Malaysia Australia Thailand Indonesia Philippines Rest of Asia-Pacific LAMEA Brazil Argentina Uruguay Saudi Arabia Rest of LAMEA Based on the type, the 'Drug-Eluting Stents (DES)' held the most dominant share as of 2020 with an overall value of USD 6.95 Billion and growing at a CAGR of 8.77%. Factors such as an abrupt increase in adopting a sedentary lifestyle that led to atherosclerosis enhance the Drug-Eluting Stents segment effectively. Moreover, the widespread use of Drug-Eluting Stents (DES) in the geriatric population will lower the risk of restenosis, which is one of the pivotal factors driving this market's growth significantly. Based on Mode of Delivery, the 'Balloon-Expandable Stents' segment is expected to dominate the market during the forecasted period owing to the higher rate of stent utilization, an increase of research activities for further improvement of this technology, and growing regulatory approvals. Based on End Users, the 'Hospitals' segment is estimated to dominate the market owing to the effective and efficient utilization of coronary stents in hospitals. It also persists of well-planned referral networks for responding effectively and efficiently to the population health needs. For patients without health insurance, the hospital expenditure on coronary stents ranges typically between USD 11,000 to USD 41,000, depending on the type of stent and the length of hospital stay. Based on Regions: North America has the most dominant regional market for coronary stents as of 2020 and is estimated to witness the same trend throughout the foreseeable future. Every year, about 647,000 people in the United States die from heart diseases, thus making it one of the leading causes of death. One out of every four deaths occur due to cardiac diseases. According to WHO, Cardiovascular diseases resulted in the death of almost 30.47 million people in the United States in 2018. A sedentary lifestyle results have led to obesity and other cardiovascular diseases such as stroke, heart attack, and ischemic heart diseases (IHD), which are driving the market growth of the U.S. Coronary Stent. Also, major innovative techniques in coronary stent technologies, such as the usage of biodegradable materials, and bifurcated stents, have further augmented the overall market growth in the United States. Asia Pacific is the fastest-growing region with the highest compound annual growth rate (CAGR) during the forecasted period. The rate of mortality due to cardiac diseases is rising abruptly in this region. About one-third of the total deaths occur due to cardiovascular diseases. According to WHO, cardiac diseases have caused more than 9.4 million deaths in 2016 in the APAC region. Factors like the growing prevalence of cardiac diseases, large population base, low manufacturing costs, and rising acceptance of advanced technologies are expected to drive market growth in this region. Moreover, the growing focus of key market leaders in this region is widely estimated to boost the coronary stents market immensely in the future. Global Coronary Stents Market: Competitive Landscape Analysis The competitive landscape analysis provides adequate details on the major competitors that are prevailing in the market environment. The comparison is performed based on the company overview, the overall potential of the market, investment in R&D, total revenue generated, market initiatives, company financials, strengths and weaknesses, production sites and facilities, production capacity, etc. Report Attribute Details Forecast Period 2020 - 2028 Market size value in 2020 USD 8.171 Billion Revenue forecast in 2028 USD 11.237 Billion Growth rate CAGR of approximately 4.78% Base year for estimation 2020 Historical data 2016 – 2019 Unit USD Billion, CAGR (2020 - 2028) Segmentation Based on Type, Based on Mode of Delivery , Based on End-User,Based on Regions. Based on Type Bare-Metal Stents, Drug-Eluting Stents, Bioabsorbable Stents. Based on Mode of Delivery Balloon-Expandable Stents, Self-Expanding Stents. Based on End-User Hospitals, Cardiac Centers, Ambulatory Surgical Centers (ASCs). Based on Region North America, Europe, Asia Pacific, LAMIA. Country Scope U.S, Canada , France, Germany ,U.K, China , Japan , India , South Korea, Mexico, Brazil ,U.A.E. etc. Company Usability Profiles Medtronic plc, Biosensors International Group Limited, Abbott, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, Cook Medical, B. Braun Melsungen AG,Terumo Corporation, Vascular Concepts, STENTYS SA. MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd, Translumina. Pricing and purchase options Avail customized purchase options to meet your exact research needs. The major players that are covered in the Coronary Stents Market report are: Medtronic plc Biosensors International Group Limited Abbott Boston Scientific Corporation BIOTRONIK SE & Co. KG Cook Medical B. Braun Melsungen AG Terumo Corporation Vascular Concepts STENTYS SA MicroPort Scientific Corporation Meril Life Sciences Pvt. Ltd Translumina Global Coronary Stents Market: Recent Developments In 2018, Cook Medical received FDA approval for launching the first five mm diameter SFA drug-eluting stent. It is implemented for the treatment of vessels which are as small as 4mm in diameter. Also, it will provide an additional option in the treatment of patients with lesions in their superficial femoral arteries (SFAs). On October 1, 2021, Medtronic Resolute Onyx Drug-Eluting Stent was the first to receive One Month DAPT indication. The Resolute Onyx DES is the one and only DES proven to be highly safe, effective, and reliable in the United States. Resolute Onyx DES, along with its biocompatible polymer and stent design, is highly effective for patients suffering from cardiac diseases. Frequently Asked Question About This Report What is the overall dollar value of the Global Coronary Stent Market? The Global Coronary Stents Market size was estimated at USD 8.171 billion in 2020 and is expected to reach a landmark of USD 11.237 billion in 2028 with a CAGR of 4.78%. What are the different key factors that are driving the overall growth of the Coronary Stents market? Major factors that are effectively and efficiently driving the coronary stents market growth include the continuous rising prevalence of cardiovascular diseases (CVDs) such as heart attack and stroke, growing geriatric population, rising occurrence for minimally invasive surgeries (MIS), and a drastic increase in the number of PCI methods. Who all are the major companies involved in the Global Coronary Stent Market? Some of the pivotal players in the coronary stents market include Abbott, C. R. Bard Inc., Terumo Corporation, Medtronic, Boston Scientific, Cook Medical, and MicroPort Scientific Corporation. Which segment accounted for the highest market share? North America significantly dominated the coronary stents market with a share of 34.7% in 2020. This is attributed to the increasing prevalence of cardiovascular diseases like heart attack, stroke, ischemic heart diseases, and consumers increased focus for better and effective treatment. N/A Chapter 1. Introduction 1.1 Study Objectives 1.2 Market Definition Table 1 Inclusions and Exclusions 1.3 Study Scope 1.3.1 Markets Covered Figure 01: Coronary Stents Market Segmentation 1.3.2 Geographic Scope Figure 02: Coronary Stents Market Geography covered 1.3.3 Years Considered 1.4 Stakeholders Chapter 2. Research Methodology 2.1 Data Procurement 2.2 Paid Database 2.2.1 Secondary Data 2.2.1.1 Key Secondary sources 2.2.2 Primary Data 2.2.2.1 Primary sources 2.2.2.2 Key industry insights 2.2.2.3 Primary interviews with experts 2.2.2.4 Key primary respondent list 2.3 Market Size Estimation 2.4 Bottom-Up and Top-Down Approaches 2.4.1 Bottom-Up Approach 2.4.1.1 Approach for arriving at market size by bottom-up analysis Figure 03: Coronary Stents Market: Bottom-Up Approach 2.4.2 Top-Down Approach 2.4.2.1 Approach for Capturing Market Size by Top-Down Analysis Figure 04: Coronary Stents Market: Top-Down Approach 2.5 Market Breakdown and Data Triangulation Figure 05: Data Triangulation 2.6 Research Methodology 2.7 Risk Assessment Table 2: Risk Assessment Chapter 3. Executive Summary 3.1 Coronary Stents Market: Post-Covid-19 Figure 06: Impact of Covid-19 on Coronary Stents Market 3.1.1 Actual Scenario Figure 07: Realistic Scenario: Coronary Stents Market, 2020–2028 (USD Million) 3.1.2 Pessimistic Scenario Figure 08: Pessimistic Scenario: Coronary Stents Market, 2020–2028 (USD Million) 3.1.3 Optimistic Scenario Figure 09: Optimistic Scenario: Coronary Stents Market, 2020–2028(USD Million) 3.1.4 Market Summary Figure 10: Drug-Eluting Stents (DES) to Witness Highest CAGR in Coronary Stents Market, By Type, During Forecast Period Figure 11: Hospitals to Witness Higher CAGR in Coronary Stents Market for End-User Segment during Forecast Period Figure 12: Balloon-Expandable Stents for Mode of Delivery to Register Highest CAGR in Coronary Stents Market during Forecast Period Figure 13: North America to Account for Largest Share of Global Coronary Stents Market In 2020 Chapter 4. Market Definitions 4.1 Market Segmentation Figure 14: Coronary Stents Market Segmentation Chapter 5. Industry Outlook 5.1 Market Snapshot 5.2 Global Coronary Stents Market 5.2.1 Global Coronary Stents market, 2020 – 2028 (USD Million) 5.3 Regional Segment Analysis 5.3.1 Global Coronary Stents market, by region, 2020 - 2028 (USD Million) 5.4 Type Segment Analysis 5.4.1 Global Coronary Stents market, by Type, 2020 - 2028 (USD Million) 5.5 End-User Analysis 5.5.1 Global Coronary Stents market, by End-User, 2020 - 2028 (USD Million) 5.6 Usage Segment Analysis 5.6.1 Global Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) 5.7 By Usage Business Analysis 5.8 Value Chain Analysis 5.9 Market Variable Analysis 5.9.1 Market Drivers Analysis 5.9.2 Market Restraints Analysis 5.10 Business Environment Analysis Tool 5.10.1 Coronary Stents market PEST analysis 5.10.2 Coronary Stents market Porter’s analysis 5.11 Penetration & Growth Prospect Mapping Chapter 6. Market Overview 6.1 Introduction 6.2 Market Dynamics Figure 15 Coronary Stents Market: Drivers, Restraints, Opportunities, and Challenges 6.2.1 Drivers Figure 16 Coronary Stents Market Drivers and Their Impact 6.2.2 Restraints Figure 17 Coronary Stents Market Restraints and Their Impact 6.2.3 Opportunities Figure 18 Coronary Stents Market Opportunities and Their Impact 6.2.4 Challenges Figure 19 Coronary Stents Market Challenges and Their Impact 6.3 Impact of Covid-19 on Coronary Stents Market 6.4 Value Chain Analysis Figure 20 Value Chain Analysis: Coronary Stents Market 6.5 Ecosystem Figure 21 Coronary Stents Market: Ecosystem Table 3 Coronary Stents Market: Ecosystem Figure 22 Revenue Shift in Coronary Stents Market 6.6 Patent Analysis Table 4 Number of Patents Registered in Coronary Stents Market in USA in Last 9 Years Figure 23 Top 13 Companies with Highest No. of Patents in Last 9 Years Figure 24 No of Patents Granted Per Year, 2019–2020 Table 5 List of Global Patents in Coronary Stents Market 6.7 Trade Analysis Figure 25 Import Data for Bare-Metal Stents, By Country, 2016–2020 (USD Thousand) Table 6 Import Data for Drug-Eluting Stents, By Country, 2016–2020 (USD Thousand) Figure 26 Import Data for Bioabsorbable Stents, By Country, 2016–2020 (USD Thousand) Figure 27 Export Data for Bare-Metal Stents, By Country, 2016–2020 (USD Thousand) Table 7 Export Data for Drug-Eluting Stents, By Country, 2016–2020 (USD Thousand) Figure 28 Export Data for Bioabsorbable Stents, By Country, 2016–2020 (USD Thousand) 6.8 Tariff Analysis 6.9 Case Study Analysis 6.10 Porter’s Five Forces Analysis Table 8 Coronary Stents Market: Porter’s Five Forces Analysis, 2020 6.10.1 Threat of New Entrants 6.10.2 Threat of Substitutes 6.10.3 Bargaining Power of Buyers 6.10.4 Bargaining Power of Suppliers 6.10.5 Degree of Competition 6.11 Technology Analysis 6.11.1 Trends in Technology (2014-2020) 6.11.2 Trends in Technology (2021-2028) Table 9 Key Regulations: Coronary Stents Market 6.12 Pricing Analysis 6.12.1 Average Price Trend Analysis (By region, By Countries) Chapter 7. Competitive & Vendor Landscape 7.1 Company Market Share Analysis Table 10: Key Players market share Figure 29: Key players market share of companies 7.2 Manufacturers Coronary Stents Manufacturing Sites, Area Served, Product Type 7.3 Coronary Stents Market Competitive Situation and Trends 7.4 Manufacturers Mergers & Acquisitions, Expansion Plans Chapter 8. Global Coronary Stents Market: Type Segment Analysis 8.1 Introduction 8.2 Sales Volume & Revenue Analysis (2020-2028) Table 11 Coronary Stents Market, By Type, 2021–2028 (USD Million) Figure 30 Coronary Stents Market, By Type Figure 31 Drug-Eluting Stents (DES) Segment to Register Highest CAGR in Coronary Stents Market During Forecast Period 8.3 Drug-Eluting Stents (DES) 8.3.1 Drug-Eluting Stents (DES) market, 2020 - 2028 (USD Million) Figure 32: Drug-Eluting Stents (DES) market, 2020 - 2028 (USD Million) 8.4 Bare-Metal Stents 8.4.1 Bare-Metal Stents market, 2020 - 2028 (USD Million) Figure 33: Bare-Metal Stents market, 2020 - 2028 (USD Million) 8.5 Bioabsorbable Stents 8.5.1 Bioabsorbable Stents market, 2020 - 2028 (USD Million) Figure 34: Bioabsorbable Stents market, 2020 - 2028 (USD Million) Chapter 9. Global Coronary Stents Market: End-User Segment Analysis 9.1 Introduction 9.2 Sales Volume & Revenue Analysis (2020-2028) Table 12: Coronary Stents Market, By End-User, 2021–2028 (USD Million) Figure 35: Coronary Stents Market, By End-User, 2021–2028 (USD Million) Figure 36: Hospitals Segment to Register Highest CAGR in Coronary Stents Market during Forecast Period 9.3 Hospitals 9.3.1 Hospitals market, 2020 - 2028 (USD Million) Figure 37: Hospitals market, 2020 - 2028 (USD Million) 9.4 Cardiac Centers 9.4.1 Cardiac Centers market, 2020 - 2028 (USD Million) Figure 38: Cardiac Centers market, 2020 - 2028 (USD Million) 9.5 Ambulatory Surgical Centers (ASCs) 9.5.1 Ambulatory Surgical Centers (ASCs) market, 2020 - 2028 (USD Million) Figure 39: Ambulatory Surgical Centers (ASCs) market, 2020 - 2028 (USD Million) Chapter 10. Global Coronary Stents Market: Mode of Delivery Segment Analysis 10.1 Introduction 10.2 Sales Volume & Revenue Analysis (2020-2028) Table 13: Coronary Stents Market, By Mode of Delivery, 2021–2028 (USD Million) Figure 40: Coronary Stents Market, By Mode of Delivery, 2021–2028 (USD Million) Figure 41: Balloon-Expandable Stents Segment to Register Highest CAGR in Coronary Stents Market during Forecast Period 10.3 Balloon-Expandable Stents 10.3.1 Balloon-Expandable Stents market, 2020 - 2028 (USD Million) Figure 42: Balloon-Expandable Stents market, 2020 - 2028 (USD Million) 10.4 Self-Expanding Stents 10.4.1 Self-Expanding Stents market, 2020 - 2028 (USD Million) Figure 43: Self-Expanding Stents market, 2020 - 2028 (USD Million) Chapter 11. Global Coronary Stents Market: Regional Outlook 11.1 North America Figure 44: North America Coronary Stents Market, By Revenue Forecast (2020-2028) 11.1.1 North America Coronary Stents market, by country, 2020 - 2028 (USD Million) Table 14: North America Coronary Stents Market, by Country, 2020-2028 Figure 45: North America Coronary Stents Market 11.1.2 North America Coronary Stents market, by Type, 2020 - 2028 (USD Million) Table15: North America Coronary Stents market, by Type, 2020 - 2028 (USD Million) Figure 46: North America Coronary Stents market, by Type, 2020 - 2028 (USD Million) 11.1.3 North America Coronary Stents market, by End-User, 2020 - 2028 (USD Million) Table 16: North America Coronary Stents market, by End-User, 2020 - 2028 (USD Million) Figure 47: North America Coronary Stents market, by End-User, 2020 - 2028 (USD Million) 11.1.4 North America Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) Table 17: North America Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) Figure 48: North America Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) 11.1.5 U.S. 11.1.5.1 U.S. Coronary Stents market, by Type, 2020 - 2028 (USD Million) Figure 49: U.S. Coronary Stents market, by Type, 2020 - 2028 (USD Million) 11.1.5.2 U.S. Coronary Stents market, by End-User, 2020 - 2028 (USD Million) Figure 50: U.S. Coronary Stents market, by End-User, 2020 - 2028 (USD Million) 11.1.5.3 U.S. Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) Figure 51: U.S. Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) 11.1.6 Canada 11.1.6.1 Canada Coronary Stents market, by Type, 2020 - 2028 (USD Million) Figure 52: Canada Coronary Stents market, by Type, 2020 - 2028 (USD Million) 11.1.6.2 Canada Coronary Stents market, by End-User, 2020 - 2028 (USD Million) Figure 53: Canada Coronary Stents market, by End-User, 2020 - 2028 (USD Million) 11.1.6.3 Canada Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) Figure 54: Canada Coronary Stents market, by End-User, 2020 - 2028 (USD Million) 11.1.6.4 Canada Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) Figure 55: Canada Coronary Stents market, by End-User, 2020 - 2028 (USD Million) 11.2 Europe Figure 56: Europe Coronary Stents Market, By Revenue Forecast (2020-2028) 11.2.1 Europe Coronary Stents market, by country, 2020 - 2028 (USD Million) Table 18: Europe Coronary Stents market, by country, 2020 - 2028 (USD Million) Figure 57: Europe Coronary Stents market, by country, 2020 - 2028 (USD Million) 11.2.2 Europe Coronary Stents market, by Type, 2020 - 2028 (USD Million) Table 19: Europe Coronary Stents market, by Type, 2020 - 2028 (USD Million) Figure 58: Europe Coronary Stents market, by Type, 2020 - 2028 (USD Million) 11.2.3 Europe Coronary Stents market, by End-User, 2020 - 2028 (USD Million) Table 20: Europe Coronary Stents market, by End-User, 2020 - 2028 (USD Million) Figure 59: Europe Coronary Stents market, by End-User, 2020 - 2028 (USD Million) 11.2.4 Europe Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) Table 21: Europe Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) Figure 60: Europe Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) 11.2.5 U.K. 11.2.5.1 U.K. Coronary Stents market, by Type, 2020 - 2028 (USD Million) Figure 61: U.K. Coronary Stents market, by Type, 2020 - 2028 (USD Million) 11.2.5.2 U.K. Coronary Stents market, by End-User, 2020 - 2028 (USD Million) Figure 62: U.K. Coronary Stents market, by End-User, 2020 - 2028 (USD Million) 11.2.5.3 U.K. Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) Figure 63: U.K. Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) 11.2.6 Germany 11.2.6.1 Germany Coronary Stents market, by Type, 2020 - 2028 (USD Million) Figure 64: Germany Coronary Stents market, by Type, 2020 - 2028 (USD Million) 11.2.6.2 Germany Coronary Stents market, by End-User, 2020 - 2028 (USD Million) Figure 65: Germany Coronary Stents market, by End-User, 2020 - 2028 (USD Million) 11.2.6.3 Germany Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) Figure 66: Germany Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) 11.2.7 France 11.2.7.1 France Coronary Stents market, by Type, 2020 - 2028 (USD Million) Figure 67: France Coronary Stents market, by Type, 2020 - 2028 (USD Million) 11.2.7.2 France Coronary Stents market, by End-User, 2020 - 2028 (USD Million) Figure 68: France Coronary Stents market, by End-User, 2020 - 2028 (USD Million) 11.2.7.3 France Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) Figure 69: France Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) 11.2.8 Rest of Europe 11.2.8.1 Rest of Europe Coronary Stents market, by Type, 2020 - 2028 (USD Million) Figure 70: Rest of Europe Coronary Stents market, by Type, 2020 - 2028 (USD Million) 11.2.8.2 Rest of Europe Coronary Stents market, by End-User, 2020 - 2028 (USD Million) Figure 71: Rest of Europe Coronary Stents market, by End-User, 2020 - 2028 (USD Million) 11.2.8.3 Rest of Europe Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) Figure 72: Rest of Europe Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) 11.3 Asia Pacific Figure 73: Asia Pacific Coronary Stents Market, By Revenue Forecast (2020-2028) 11.3.1 Asia Pacific Coronary Stents market, by country, 2020 - 2028 (USD Million) Table 22: Asia Pacific Coronary Stents market, by country, 2020 - 2028 (USD Million) Figure 74: Asia Pacific Coronary Stents market, by country, 2020 - 2028 (USD Million) 11.3.2 Asia Pacific Coronary Stents market, by Type, 2020 - 2028 (USD Million) Table 23: Asia Pacific Coronary Stents market, by Type, 2020 - 2028 (USD Million) Figure 75: Asia Pacific Coronary Stents market, by Type, 2020 - 2028 (USD Million) 11.3.3 Asia Pacific Coronary Stents market, by End-User, 2020 - 2028 (USD Million) Table 24: Asia Pacific Coronary Stents market, by End-User, 2020 - 2028 (USD Million) Figure 76 Asia Pacific Coronary Stents market, by End-User, 2020 - 2028 (USD Million) 11.3.4 Asia Pacific Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) Table 25: Asia Pacific Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) Figure 77: Asia Pacific Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) 11.3.5 China 11.3.5.1 China Coronary Stents market, by Type, 2020 - 2028 (USD Million) Figure 78: China Coronary Stents market, by Type, 2020 - 2028 (USD Million) 11.3.5.2 China Coronary Stents market, by End-User, 2020 - 2028 (USD Million) Figure 79: China Coronary Stents market, by End-User, 2020 - 2028 (USD Million) 11.3.5.3 China Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) Figure 80: China Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) 11.3.6 India 11.3.6.1 India Coronary Stents market, by Type, 2020 - 2028 (USD Million) Figure 81: India Coronary Stents market, by Type, 2020 - 2028 (USD Million) 11.3.6.2 India Coronary Stents market, by End-User, 2020 - 2028 (USD Million) Figure 82: India Coronary Stents market, by End-User, 2020 - 2028 (USD Million) 11.3.6.3 India Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) Figure 83: India Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) 11.3.7 Japan 11.3.7.1 Japan Coronary Stents market, by Type, 2020 - 2028 (USD Million) Figure 84: Japan Coronary Stents market, by Type, 2020 - 2028 (USD Million) 11.3.7.2 Japan Coronary Stents market, by End-User, 2020 - 2028 (USD Million) Figure 85: Japan Coronary Stents market, by End-User, 2020 - 2028 (USD Million) 12.3.7.3 Japan Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) Figure 86: Japan Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) 11.3.8 South Korea 11.3.8.1 South Korea Coronary Stents market, by Type, 2020 - 2028 (USD Million) Figure 87: South Korea Coronary Stents market, by Type, 2020 - 2028 (USD Million) 11.3.8.2 South Korea Coronary Stents market, by End-User, 2020 - 2028 (USD Million) Figure 88: South Korea Coronary Stents market, by End-User, 2020 - 2028 (USD Million) 12.3.8.3 South Korea Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) Figure 89: South Korea Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) 11.3.9 Rest of APAC 11.3.9.1 Rest of APAC Coronary Stents market, by Type, 2020 - 2028 (USD Million) Figure 90 Rest of APAC Coronary Stents market, by Type, 2020 - 2028 (USD Million) 11.3.9.2 Rest of APAC Coronary Stents market, by End-User, 2020 - 2028 (USD Million) Figure 91: Rest of APAC Coronary Stents market, by End-User, 2020 - 2028 (USD Million) 11.3.9.3 Rest of APAC Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) Figure 92: Rest of APAC Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) 11.4 Latin America Figure 93: Latin America Coronary Stents Market, By Revenue Forecast (2020-2028) 11.4.1 Latin America Coronary Stents market, by country, 2020 - 2028 (USD Million) Table 26: Latin America Coronary Stents market, by country, 2020 - 2028 (USD Million) Figure 94: Latin America Coronary Stents market, by country, 2020 - 2028 (USD Million) 11.4.2 Latin America Coronary Stents market, by Type, 2020 - 2028 (USD Million) Table 27: Latin America Coronary Stents market, by Type, 2020 - 2028 (USD Million) Figure 95: Latin America Coronary Stents market, by Type, 2020 - 2028 (USD Million) 11.4.3 Latin America Coronary Stents market, by End-User, 2020 - 2028 (USD Million) Table 28: Latin America Coronary Stents market, by End-User, 2020 - 2028 (USD Million) Figure 96: Latin America Coronary Stents market, by End-User, 2020 - 2028 (USD Million) 11.4.4 Latin America Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) Table 29: Latin America Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) Figure 97: Latin America Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) 11.4.5 Brazil 11.4.5.1 Brazil Coronary Stents market, by Type, 2020 - 2028 (USD Million) Figure 98: Brazil Coronary Stents market, by Type, 2020 - 2028 (USD Million) 11.4.5.2 Brazil Coronary Stents market, by End-User, 2020 - 2028 (USD Million) Figure 99: Brazil Coronary Stents market, by End-User, 2020 - 2028 (USD Million) 11.4.5.3 Brazil Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) Figure 100: Brazil Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) 11.4.6 Mexico 11.4.6.1 Mexico Coronary Stents market, by Type, 2020 - 2028 (USD Million) Figure 101: Mexico Coronary Stents market, by Type, 2020 - 2028 (USD Million) 11.4.6 2 Mexico Coronary Stents market, by End-User, 2020 - 2028 (USD Million) Figure 102: Mexico Coronary Stents market, by End-User, 2020 - 2028 (USD Million) 11.4.6.3 Mexico Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) Figure 103: Mexico Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) 11.4.7 Rest of the Latin America 11.4.7.1 Rest of the Latin America Coronary Stents market, by Type, 2020 - 2028 (USD Million) Figure 104: Rest of the Latin America Coronary Stents market, by Type, 2020 - 2028 (USD Million) 11.4.7.2 Rest of the Latin America Coronary Stents market, by End-User, 2020 - 2028 (USD Million) Figure 105: Rest of the Latin America Coronary Stents market, by End-User, 2020 - 2028 (USD Million) 11.4.7.3 Rest of the Latin America Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) Figure 106: Rest of the Latin America Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) 11.5 MEA Figure 107: MEA Coronary Stents Market, By Revenue Forecast (2020-2028) 11.5.1 MEA Coronary Stents market, by Type, 2020 - 2028 (USD Million) Figure 108: MEA Coronary Stents market, by Type, 2020 - 2028 (USD Million) 11.5.2 MEA Coronary Stents market, by End-User, 2020 - 2028 (USD Million) Figure 109: MEA Coronary Stents market, by End-User, 2020 - 2028 (USD Million) 11.5.3 MEA Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) Figure 110: MEA Coronary Stents market, by Mode of Delivery, 2020 - 2028 (USD Million) Chapter 12. Competitive Landscape 12.1 Medtronic plc. 12.1.1 Company overview 12.1.2 Financial performance 12.1.3 Product Portfolio Analysis 12.1.4 Business Strategy & Recent Development 12.2 Biosensors International Group Limited. 12.2 .1 Company overview 12.2 .2 Financial performance 12.2 .3 Product Portfolio Analysis 12.2 .4 Business Strategy & Recent Development 12.3 Abbott. 12.3.1 Company overview 12.3.2 Financial performance 12.3.3 Product Portfolio Analysis 12.3.4 Business Strategy & Recent Development 12.4 Boston Scientific Corporation. 12.4.1 Company overview 12.4.2 Financial performance 12.4.3 Product Portfolio Analysis 12.4.4 Business Strategy & Recent Development 12.5 BIOTRONIK SE & Co. KG. 12.5.1 Company overview 12.5.2 Financial performance 12.5.3 Product Portfolio Analysis 12.5.4 Business Strategy & Recent Development 12.6 Cook Medical. 12.6.1 Company overview 12.6.2 Financial performance 12.6.3 Product Portfolio Analysis 12.6.4 Business Strategy & Recent Development 12.7 B. Braun Melsungen AG. 12.7.1 Company overview 12.7.2 Financial performance 12.7.3 Product Portfolio Analysis 12.7.4 Business Strategy & Recent Development 12.8 Terumo Corporation. 12.8.1 Company overview 12.8.2 Financial performance 12.8.3 Product Portfolio Analysis 12.8.4 Business Strategy & Recent Development 12.9 Vascular Concepts. 12.9.1 Company overview 12.9.2 Financial performance 12.9.3 Product Portfolio Analysis 12.9.4 Business Strategy & Recent Development 12.10 STENTYS SA. 12.10.1 Company overview 12.10.2 Financial performance 12.10.3 Product Portfolio Analysis 12.10.4 Business Strategy & Recent Development 12.11 MicroPort Scientific Corporation. 12.11.1 Company overview 12.11.2 Financial performance 12.11.3 Product Portfolio Analysis 12.11.4 Business Strategy & Recent Development 12.12 Meril Life Sciences Pvt. Ltd. 12.12.1 Company overview 12.12.2 Financial performance 12.12.3 Product Portfolio Analysis 12.12.4 Business Strategy & Recent Development 12.13 Translumina. 12.13.1 Company overview 12.13.2 Financial performance 12.13.3 Product Portfolio Analysis 12.13.4 Business Strategy & Recent Development